Melanoma Cell Death Mechanisms
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Melanoma Cell Death Mechanisms' 의 참고문헌
Whole-genome landscapes of major melanoma subtypes
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL): a possible pathogenic role in chronic plaque psoriasis
Trametinib: a MEK inhibitor for management of metastatic melanoma
Therapeutic targeting of autophagy in disease: biology and pharmacology
The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031
Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines
Targeting KIT for treatment of advanced melanoma
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function
Resistant mechanisms to BRAF inhibitors in melanoma
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: where to next?
Regulation of apoptotic and necroptotic cell death in skin cancer
Profile of selumetinib and its potential in the treatment of melanoma
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification
Phase II study of Everolimus in metastatic malignant melanoma (NCCTG-N0377, alliance)
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Molecular mechanisms of cell death: recommendations of the nomenclature committee on Cell death 2018
Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
Melanoma--an unlikely poster child for personalized cancer therapy
MTOR is activated in the majority of malignant melanomas
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
MEK inhibitors in the treatment of metastatic melanoma and solid tumors
Inhibition of autophagy with chloroquine is effective in melanoma
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
Genetic alterations in primary acral melanoma and acral melanocytic nevus in Korea: common mutated genes show distinct cytomorphological features
Developments in targeted therapy in melanoma
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma
Cobimetinib for metastatic melanoma
[2017]
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
Autophagy: cellular and molecular mechanisms
Autophagy modulation: a target for cancer treatment development
Apoptosis in cancer: from pathogenesis to treatment
Anti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma
Analysis of mTOR gene aberrations in melanoma patients and evaluation of their sensitivity to PI3K-AKT-mTOR pathway inhibitors
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
'
Melanoma Cell Death Mechanisms'
의 유사주제(
